Open Access
| Numéro |
Ann Toxicol Anal
Volume 24, Numéro 1, 2012
|
|
|---|---|---|
| Page(s) | 49 - 58 | |
| DOI | https://doi.org/10.1051/ata/2012002 | |
| Publié en ligne | 30 mai 2012 | |
- Boucher A, Vilette P, Crassard N, Bernard N, Descotes J. Urinary toxicological screening: analytical interference between niflumic acid and cannabis. Arch Pediatr. 2009; 16(11): 1457–1460. [CrossRef] [PubMed] [Google Scholar]
- Delacour H, Servonnet A, Gardet V. Dépistage du cannabis dans les urines, attention à l'acide niflumique. Ann Toxicol Anal. 2005; 17(3): 203–206. [CrossRef] [EDP Sciences] [Google Scholar]
- Moeller KE, Lee KC, Kissack JC. Urine drug screening: practical guide for clinicians. Mayo Clin Proc. 2008; 83(1): 66–76. [CrossRef] [PubMed] [Google Scholar]
- Instruction n° 22000/DEF/GEND/RH du 13 février 2008 relative aux normes d'aptitude médicale des personnels militaires de la gendarmerie 2008. [Google Scholar]
- Feinberg M, Boulanger B, Dewe W, Hubert P. New advances in method validation and measurement uncertainty aimed at improving the quality of chemical data. Anal Bioanal Chem. 2004; 380(3): 502–514. [CrossRef] [PubMed] [Google Scholar]
- Yoshida K, Tsukamoto T, Torii H, Doi T, Naeshiro I, Uemura I, Tanayama S. Metabolism of ipriflavone (TC-80) in rats. Radioisotopes. 1985; 34(11): 612–617. [CrossRef] [PubMed] [Google Scholar]
- Heinonen SM, Wähälä K, Adlercreutz H. Metabolism of isoflavones in human subjects. Phytochemistry Reviews. 2002; 1(2): 175–182. [CrossRef] [Google Scholar]
- Kreider RB, Wilborn CD, Taylor L, Campbell B, Almada AL, Collins R, Cooke M, Earnest CP, Greenwood M, Kalman DS, Kerksick CM, Kleiner SM, Leutholtz B, Lopez H, Lowery LM, Mendel R, Smith A, Spano M, Wildman R, Willoughby DS, Ziegenfuss TN, Antonio J. ISSN exercise & sport nutrition review: research & recommendations. J Int Soc Sports Nutr. 2010; 7: 7–50. [CrossRef] [PubMed] [Google Scholar]
- Feuer L, Farkas L, Nogradi M, Vermes B, Gottsegen A, Wolfner A. Metabolic 5-methyl-isoflavone-derivatives, process for the preparation thereof and compositions containing the same. US patent 4163746. 1979. [Google Scholar]
- Incledon T, Van Gammeren D, Antonio J. The effects of 5-methyl-7-methoxyisoflavone on body composition and performance in college-aged men. Med Sci Sports Exer. 2001; 33(5): S338. [CrossRef] [Google Scholar]
- Wilborn CD, Taylor LW, Campbell BI, Kerksick C, Rasmussen CJ, Greenwood M, Kreider RB. Effects of methoxyisoflavone, ecdysterone, and sulfo-polysaccharide supplementation on training adaptations in resistance-trained males. J Int Soc Sports Nutr. 2006; 3: 19–27. [CrossRef] [PubMed] [Google Scholar]
- Dumestre-Toulet V. Se doper via Internet ? Un jeu... de souris ! Ann Toxicol Anal. 2000; 12(1): 19–25. [CrossRef] [EDP Sciences] [Google Scholar]
- Monostory K, Vereczkey L, Levai F, Szatmari I. Ipriflavone as an inhibitor of human cytochrome P450 enzymes. Br J Pharmacol. 1998; 123(4): 605–610. [CrossRef] [PubMed] [Google Scholar]
- Lecompte Y, Salle S, Roussel O, Hervé S, Messines O, Perrin M. Influence du seuil de confirmation lors du dépistage urinaire de l’usage du cannabis : à propos de cinq années de dépistages réalisés au sein de la Gendarmerie nationale. Médecine et Armées. 2011; 39(4): 35–46. [Google Scholar]
- CEDIA® THC Cross-Reactivity Table. Document consulté sur le site https://fscimage.fishersci.com/images/D15921~.pdf le 21 novembre 2011. [Google Scholar]